Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.

Nine neurodegenerative diseases, collectively referred to as polyglutamine (polyQ) diseases, are caused by expansion of a coding CAG DNA trinucleotide repeat. PolyQ diseases show a strong inverse correlation between CAG repeat length and age of disease onset (AO). Despite this, individuals with identical repeat expansion alleles can have highly variable disease onset indicating that other factors also influence AO. We examined AO in 148 individuals in 57 sibships from the SCA2 founder population in Cuba. The mutant CAG repeat allele explained 57% of AO variance. To estimate heritability of the residual variance after correction for SCA2 repeat length, we applied variance component analysis and determined the coefficient of intraclass correlation. We found that 55% of the residual AO variance was familial. To test candidate modifier alleles in this population, we selected 64 unrelated individuals from a set of 394 individuals who were highly discordant for AO after correction for SCA2 CAG repeat length. We hypothesized that long normal alleles in the other 8 polyQ disease genes were associated with premature disease onset in SCA2. Of the 8 genes tested, only long normal CAG repeats in the CACNA1A gene were associated with disease onset earlier than expected based on SCA2 CAG repeat size using non-parametric tests for alleles (P < 0.04) and genotypes (P < 0.023) after correction for multiple comparisons. CACNA1A variation explained 5.8% of the residual variation in AO. The CACNA1A calcium channel subunit represents an excellent candidate as a modifier of disease in SCA2. It is highly expressed in Purkinje cells (PCs) and is essential for the generation of the P/Q current and the complex spike in PCs. In contrast to other polyQ proteins, which are nuclear, the CACNA1A and SCA2 proteins are both cytoplasmic. Furthermore, small pathologic expansions of the polyQ domain in the CACNA1A protein lead to PC degeneration in SCA6. Future studies are needed to determine whether the modifier effect of CACNA1A relates to neuronal dysfunction or cell death of Purkinje neurons.

[1]  H. Zoghbi,et al.  Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. , 1994, American journal of human genetics.

[2]  C M Gomez.  Polyglutamine aggregates in SCA6 Purkinje cells , 2001, Neurology.

[3]  I. Kanazawa,et al.  Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. , 1999, Human molecular genetics.

[4]  R. Sinke,et al.  Spinocerebellar ataxias in the Netherlands: Prevalence and age at onset variance analysis , 2002, Neurology.

[5]  D. Jeste,et al.  Reduced Purkinje cell density in Huntington's disease , 1984, Experimental Neurology.

[6]  S. Pulst,et al.  CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). , 2000, Human molecular genetics.

[7]  Y. Agid,et al.  Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. , 1997, Human molecular genetics.

[8]  Stefan M Pulst,et al.  Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. , 2003, Human molecular genetics.

[9]  M. MacDonald,et al.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease , 2003, American journal of medical genetics. Part A.

[10]  S. Pulst,et al.  Spinocerebellar Ataxia Type 2: Genotype and Phenotype in German Kindreds , 1997 .

[11]  Fumiaki Tanaka,et al.  Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. , 2005, Brain : a journal of neurology.

[12]  J. Beckmann,et al.  Genetic mapping of the spinocerebellar ataxia 2 (SCA2) locus on chromosome 12q23-q24.1. , 1995, Genomics.

[13]  Pathogenic effect of an intermediate-size SCA-6 allele (CAG)19 in a homozygous patient , 2001, Neurology.

[14]  Jane S. Paulsen,et al.  A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. , 2003, American journal of human genetics.

[15]  S. Pulst,et al.  SCA2 trinucleotide expansion in German SCA patients , 1997, Neurogenetics.

[16]  C. Fletcher,et al.  Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  S. Pulst,et al.  Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human , 2000, Nature Genetics.

[18]  H. Hendriks,et al.  Age at onset variance analysis in spinocerebellar ataxias: A study in a Dutch–French cohort , 2005, Annals of neurology.

[19]  A. Dürr,et al.  Genetics of movement disorders , 1996, Current opinion in neurology.

[20]  S. Pulst.  Genetics of Movement Disorders , 2002 .

[21]  D. Condorelli,et al.  Clinical and molecular analysis of 11 Sicilian SCA2 families: influence of gender on age at onset , 1999, European journal of neurology.

[22]  A. Koeppen,et al.  Synapses in the hereditary ataxias. , 1999, Journal of neuropathology and experimental neurology.

[23]  D. Geschwind,et al.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. , 1997, American journal of human genetics.

[24]  G Norbury,et al.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Pulst,et al.  Expression of ataxin‐2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2 , 1999, Annals of neurology.

[26]  S. Pulst.  Spinocerebellar Ataxia 2 (SCA2) , 2003 .

[27]  Karen Marder,et al.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Tsien,et al.  Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Ronald Wetzel,et al.  Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Georg Auburger,et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.